Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
30 Sep 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/biogen-answers-cries-bill-bill-bill-supporting-web-series-get-science-guy-back-lab
29 Sep 2025
// BIOSPACE
https://www.biospace.com/business/biogen-shuffles-20-staff-after-ending-aav-work
28 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/28/3157391/0/en/LEQEMBI-lecanemab-IV-Maintenance-Dosing-for-the-Treatment-of-Early-Alzheimer-s-Disease-Approved-in-China.html
26 Sep 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/biogen-officially-ends-all-aav-gene-therapy-work-prompting-team-restructure
24 Sep 2025
// PRESS RELEASE
https://investors.biogen.com/news-releases/news-release-details/biogen-provides-regulatory-update-high-dose-regimen-nusinersen
24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155366/0/en/LEQEMBI-Lecanemab-Approved-for-the-Treatment-of-Alzheimer-s-Disease-in-Australia.html
REF. STANDARDS & IMPURITIES
Inspections and registrations
ABOUT THIS PAGE
Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen
Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen
Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen